After longtime biotech executive Sam Truex announced last year she was shutting down her short-lived immunology startup Quench Bio, she said she planned to stay at Atlas Venture to help build a new startup with many of her erstwhile Quench employees.
Quench Bio’s short journey has come to an end after the biotech startup found that its target was simply undruggable.